Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
The Prostate|April 19, 2007
Immunological evaluation of neoadjuvant peptide vaccination before radical prostatectomy for patients with localized prostate cancerMasanori Noguchi, Akihisa Yao, Mamoru Harada, et al.
International Journal of Oncology|November 8, 2006
Anti-cancer vaccine candidates in specific immunotherapy for bladder carcinomaYoshihiro Komohara, Mamoru Harada, Yoshimi Arima, et al.
Experimental and Therapeutic Medicine|September 21, 2012
A β-tubulin 5-derived peptide induces cytotoxic T lymphocytes restricted to the HLA-A24 allele in prostate cancer patientsNobukazu Komatsu, Yasunobu Terasaki, Fukuko Moriya, et al.
Oncology Reports|November 6, 2007
HLA-G as a target molecule in specific immunotherapy against renal cell carcinomaYoshihiro Komohara, Mamoru Harada, Yuki Ishihara, et al.
Oncology Reports|October 5, 2007
New peptides of the polycomb group protein enhancer of zeste homolog 2 with the potential to induce cancer-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2+ prostate cancer patientsYukoh Itoh, Yoshihiro Komohara, Nobukazu Komatsu, et al.
BMC Cancer|December 31, 2013
A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling timeMasanori Noguchi, Fukuko Moriya, Shigetaka Suekane, et al.
Human Vaccines & Immunotherapeutics|February 5, 2013
Current status of immunotherapy for the treatment of biliary tract cancerRyuji Takahashi, Munehiro Yoshitomi, Shigeru Yutani, et al.
The Journal of Urology|February 14, 2007
Identification of target antigens in specific immunotherapy for renal cell carcinomaYoshihiro Komohara, Mamoru Harada, Yoshimi Arima, et al.
Cancer Science|January 15, 2004
Phase I trial of patient-oriented vaccination in HLA-A2-positive patients with metastatic hormone-refractory prostate cancerMasanori Noguchi, Kyogo Itoh, Shigetaka Suekane, et al.
Cancer Science|June 26, 2018
Survival analysis of multiple peptide vaccination for the selection of correlated peptides in urological cancersMasanori Noguchi, Noriko Koga, Fukuko Moriya, et al.
Pageof 10